United States · FDA National Drug Code directory
Belladonna
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63545-417_dc15962b-4af0-f049-e053-2995a90ab195
- Product NDC
- 63545-417
- Form
- PELLET
- Composition / generic term
- Belladonna
- Labeler
- Hahnemann Laboratories, INC.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20220407
- Source listing expiry
- 20261231
Source-listed ingredients
- ATROPA BELLADONNA — 500 [hp_C]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 200 PELLET in 1 VIAL, GLASS (63545-417-01) · 63545-417-01
- 500 PELLET in 1 VIAL, GLASS (63545-417-02) · 63545-417-02
- 3000 PELLET in 1 BOTTLE, GLASS (63545-417-03) · 63545-417-03
- 10000 PELLET in 1 BOTTLE, GLASS (63545-417-04) · 63545-417-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →